US 12,263,116 B2
Dry eye treatment systems
Paul Badawi, Menlo Park, CA (US)
Assigned to Sight Sciences, Inc., Menlo Park, CA (US)
Filed by Sight Sciences, Inc., Menlo Park, CA (US)
Filed on Feb. 3, 2021, as Appl. No. 17/166,619.
Application 17/166,619 is a continuation of application No. 16/059,281, filed on Aug. 9, 2018, granted, now 10,925,765.
Application 16/059,281 is a continuation of application No. 15/442,003, filed on Feb. 24, 2017, granted, now 10,052,226, issued on Aug. 21, 2018.
Application 15/442,003 is a continuation of application No. 15/364,070, filed on Nov. 29, 2016, granted, now 9,844,459, issued on Dec. 19, 2017.
Application 15/364,070 is a continuation of application No. 13/645,985, filed on Oct. 5, 2012, granted, now 9,510,972, issued on Dec. 6, 2016.
Application 13/645,985 is a continuation in part of application No. 13/343,407, filed on Jan. 4, 2012, granted, now 9,724,230, issued on Aug. 8, 2017.
Prior Publication US 2021/0177647 A1, Jun. 17, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 7/00 (2006.01); A61F 7/02 (2006.01); A61F 9/00 (2006.01); A61F 13/12 (2006.01); A61M 37/00 (2006.01); A61M 35/00 (2006.01)
CPC A61F 7/007 (2013.01) [A61F 7/02 (2013.01); A61F 9/0008 (2013.01); A61F 9/0017 (2013.01); A61F 13/124 (2013.01); A61M 37/00 (2013.01); A61F 2007/0004 (2013.01); A61F 2007/0075 (2013.01); A61F 2007/0078 (2013.01); A61F 2007/0086 (2013.01); A61F 2007/0093 (2013.01); A61F 2007/0094 (2013.01); A61F 2007/0095 (2013.01); A61F 2007/0096 (2013.01); A61F 2007/0226 (2013.01); A61F 2007/0242 (2013.01); A61F 2007/0244 (2013.01); A61M 35/10 (2019.05); A61M 2037/0007 (2013.01); A61M 2205/18 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A treatment system comprising:
a controller;
a connecting cable; and
a strip attachable to a first eyelid and to a second eyelid, wherein the strip has an open first end and a closed second end, wherein the open first end is opposite the closed second end, and wherein energy is emittable to the first eyelid and/or to the second eyelid via the strip,
wherein the open first end comprises a first portion and a second portion separated by a gap, wherein the gap is configured to be larger when a person has their eyes open than when the person has their eyes closed,
wherein when the treatment system is in an assembled configuration, the connecting cable extends from the closed second end and connects the strip to the controller,
wherein a treatment therapy is controllable via the controller, and
wherein the strip has a thickness of up to 3.175 mm such that the first eyelid and/or the second eyelid are allowed to blink naturally without restriction from the strip.